Jbm (Healthcare) Ltd
HKEX:2161

Watchlist Manager
Jbm (Healthcare) Ltd Logo
Jbm (Healthcare) Ltd
HKEX:2161
Watchlist
Price: 2.78 HKD 0.36%
Market Cap: 2.3B HKD

Jbm (Healthcare) Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jbm (Healthcare) Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Jbm (Healthcare) Ltd
HKEX:2161
EPS (Diluted)
HK$0
CAGR 3-Years
100%
CAGR 5-Years
37%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
EPS (Diluted)
HK$0
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
19%
U
United Laboratories International Holdings Ltd
HKEX:3933
EPS (Diluted)
ÂĄ1
CAGR 3-Years
46%
CAGR 5-Years
39%
CAGR 10-Years
29%
Sino Biopharmaceutical Ltd
HKEX:1177
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-37%
CAGR 5-Years
9%
CAGR 10-Years
5%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
EPS (Diluted)
HK$0
CAGR 3-Years
-13%
CAGR 5-Years
0%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jbm (Healthcare) Ltd
Glance View

Market Cap
2.3B HKD
Industry
Pharmaceuticals

JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Intrinsic Value
4.38 HKD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Jbm (Healthcare) Ltd's EPS (Diluted)?
EPS (Diluted)
0.2 HKD

Based on the financial report for Mar 31, 2025, Jbm (Healthcare) Ltd's EPS (Diluted) amounts to 0.2 HKD.

What is Jbm (Healthcare) Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
37%

Over the last year, the EPS (Diluted) growth was 60%. The average annual EPS (Diluted) growth rates for Jbm (Healthcare) Ltd have been 100% over the past three years , 37% over the past five years .

Back to Top